Document Detail


A 6-month randomized pilot study of black tea and cardiovascular risk factors.
MedLine Citation:
PMID:  17892999     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The effects of black tea consumption on cardiovascular risk factors have been inconsistent in previous randomized trials, all of which have been limited to a few weeks duration.
METHODS: We conducted a pilot parallel-design randomized controlled trial among 31 adults aged 55 years and older with either diabetes or 2 other cardiovascular risk factors but no established clinical cardiovascular disease. Participants were randomized to drink 3 glasses daily of either a standardized black tea preparation or water for 6 months. Cardiovascular risk factors were measured at the beginning and conclusion of the study.
RESULTS: Three participants dropped out of the study, leaving 14 participants assigned to tea and 14 assigned to water eligible for analyses. We found no statistically significant effects of black tea on cardiovascular biomarkers, including lipids, inflammatory markers, hemoglobin, adhesion molecules, prothrombotic and fibrinolytic parameters, and lipoprotein oxidizability. Assignment to tea did not appreciably influence blood pressure, and heart rate among participants assigned to tea was marginally higher than among control participants at 3 months (P = .07) but not 6 months.
CONCLUSIONS: In this randomized trial of black tea intake over 6 months among older adults with known cardiovascular risk factors, black tea did not appreciably influence any traditional or novel biomarkers of cardiovascular risk. Longer randomized trials are needed to verify the inverse association of tea with risk of cardiovascular disease seen in cohort studies and identify potential candidate mechanisms for such an association.
Authors:
Kenneth J Mukamal; Kristen MacDermott; Joe A Vinson; Noriko Oyama; Warren J Manning; Murray A Mittleman
Related Documents :
21867559 - Assessment of an in vitro whole cigarette smoke exposure system: the borgwaldt rm20s 8-...
20647859 - Prehypertension and the risk for cardiovascular disease in the japanese general populat...
18349749 - Hyperuricemia, gout and the metabolic syndrome.
8252559 - Congenital heart disease in adolescents and adults. teratology, genetics, and recurrenc...
19665709 - Cardiovascular risk in early bereavement: a literature review and proposed mechanisms.
22411299 - Situational ambiguity and gendered patterns of arrest for intimate partner violence.
20930259 - Partnership, sex, and marginalization: moving the global fund sexual orientation and ge...
10594489 - A cohort study on the risk of acute liver injury among users of ketoconazole and other ...
8216879 - Event-related potentials in women at risk for alcoholism.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American heart journal     Volume:  154     ISSN:  1097-6744     ISO Abbreviation:  Am. Heart J.     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-09-25     Completed Date:  2007-11-06     Revised Date:  2011-09-26    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  724.e1-6     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02446, USA. kmukamal@bidmc.harvard.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Biological Markers / blood
Cardiovascular Diseases / blood*,  epidemiology*
Diabetes Mellitus / blood
Female
Humans
Male
Middle Aged
Pilot Projects
Risk Factors
Tea*
Grant Support
ID/Acronym/Agency:
M01 RR001032-290863/RR/NCRR NIH HHS; M01 RR001032-30A10863/RR/NCRR NIH HHS; R21 AT001899-01A1/AT/NCCAM NIH HHS; R21 AT001899-02/AT/NCCAM NIH HHS; R21AT01899/AT/NCCAM NIH HHS; RR01032/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Tea
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and dec...
Next Document:  Effects of intra-aortic balloon counterpulsation on coronary pressure in patients with stenotic coro...